Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-12-2022 | Dupilumab | Case report

Dupilumab/prednisolone

Eosinophilic granulomatosis with polyangiitis and unmasking of disease: 7 case reports

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Wechsler ME, et al. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis. The Journal of Allergy and Clinical Immunology in Practice 10 : 2695-2709, No. 10, Oct 2022. Available from: URL: http://doi.org/10.1016/j.jaip.2022.05.019 Wechsler ME, et al. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis. The Journal of Allergy and Clinical Immunology in Practice 10 : 2695-2709, No. 10, Oct 2022. Available from: URL: http://​doi.​org/​10.​1016/​j.​jaip.​2022.​05.​019
Metadata
Title
Dupilumab/prednisolone
Eosinophilic granulomatosis with polyangiitis and unmasking of disease: 7 case reports
Publication date
01-12-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-28983-y

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Dexamethasone

Case report

Tretinoin

Case report

Loxapine

Case report

Isotretinoin